ProstaGene

ProstaGene ProstaGene is a biotechnology start up company that is developing technology based on patents of the Pestell.

ProstaGene is a biotechnology start up company that is developing technology based on patents of the Founder, Dr. Richard G. ProstaGene LLC integrates proprietary molecular diagnostics with novel therapeutic screening and commercial experience in order to develop novel treatments for cancer. The company has developed a diagnostic test that distinguishes benign from malignant prostate cancer with a

predictive value of >98% in two retrospective clinical studies. The company has developed a prognostic test that defines a group of patients with poor outcome based on a signature of gene expression in the patients prostate tumor. The company has developed a novel platform for preclinical testing of therapies for metastatic prostate cancer in immune competent mice. The company has identified a therapeutic for metastatic prostate cancer that has shown to be highly effective in preclinical testing.

Address

Wynnewood, PA
19096

Website

Alerts

Be the first to know and let us send you an email when ProstaGene posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to ProstaGene:

Shortcuts

Share

Category